As we kick off 2021, there’s no shortage of medical news for healthcare providers to catch up on. To save you some time, we’ve curated a few top stories from this week.
Read on for a quick roundup of this week’s top healthcare news.
“People who get vaccinated against Covid-19 at Dodger Stadium leave with inoculation against the virus, a band-aid on their arm, and a CDC card with handwritten details such as when it was provided and which type of vaccine it was.”
“Although the benefits of telepharmacy for both community- based pharmacists and patients are clear, only 24 states permit community pharmacists to use telepharmacy models.8 Thus, there is an obvious need for increased advocacy for telepharmacy during and beyond the COVID-19 pandemic.”
“The vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases.”
"Our return to 'normal' life after vaccination is going to be gradual," Merson said. "It will not be like opening and closing a book or turning on or off a light switch. And how fast this will happen is going to depend how quickly we vaccinate the population and reach herd immunity."
"The most common reasons participants gave for accepting a telehealth appointment during the COVID crisis were new rash (11.6%), eczema (9.8%) and psoriasis (9.1%), the authors report."
"A new generation of therapeutics nearing approval and groundbreaking research exploring factors ranging from genetics to comorbidity associations could move the focus of plaque psoriasis treatment from control to cure within 5 to 10 years, according to a panel of experts speaking on the Dermatology Times® Viewpoints video program."
"Of 178 patients studied, 32 (18%) developed COVID-19. The rate of COVID-19 infection in Latino patients with rheumatic disease was three times as high as that of the general Latino population. No one was admitted to the intensive care unit. The researchers found that a BMI >30.35 kg/m2 increased the risk for COVID-19, and COVID-19 was a risk factor for flare-up of rheumatic disease."
"Researchers have observed an association between chronic systemic inflammation and increased CVD risk in RA and diabetes, suggesting a link between the 2 diseases.4-6 The increased risk for type 2 diabetes (T2D) in patients with RA has been documented; research results presented at the 2020 European Association for the Study of Diabetes (EASD) meeting showed that adults with vs without RA were 23% more likely to develop T2D.4 Previous research has also suggested that chronic inflammation associated with uncontrolled RA may be a pathophysiologic driver in the development of diabetes."
“AI has the potential to be used nearly everywhere in patient care, “but more specifically, there is great opportunity for use of AI in automated detection of disease; automated disease characterization, such as in severity grading; big data assimilation for risk stratification or diagnostic accuracy; enabling next-generation disease interrogation, creating opportunities not possible previously; enhancing current analysis platforms to improve efficiency and accuracy of workflow; and opportunities in pattern recognition and phenotype classification using pharmacogenomics or imaging genomics to understand underlying diseases.”